Related Experiment Video

Updated: Oct 26, 2026

Assay for Adhesion and Agar Invasion in S. cerevisiae
04:36

Assay for Adhesion and Agar Invasion in S. cerevisiae

Published on: November 8, 2006

Kampanols: novel Ras farnesyl-protein transferase inhibitors from Stachybotrys kampalensis

S B Singh1, D L Zink, M Williams

  • 1Merck Research Laboratories, Rahway, NJ 07065, USA.

Bioorganic & Medicinal Chemistry Letters
|January 5, 1999
PubMed

Insights

New natural compounds called kampanols specifically inhibit farnesyl-protein transferase (FPTase), an enzyme crucial for Ras protein modification, offering potential as anticancer agents for mutated ras oncogene tumors.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Natural Product Chemistry

Background:

  • Farnesyl-protein transferase (FPTase) is essential for post-translational modification of the Ras protein.
  • Mutated ras oncogenes drive cell transformation and are implicated in various cancers.
  • FPTase inhibitors represent a potential therapeutic strategy for ras-driven tumors.

Purpose of the Study:

  • To discover and characterize novel, specific inhibitors of FPTase from natural product extracts.
  • To evaluate the anticancer potential of isolated compounds.

Main Methods:

  • Screening of natural product extracts for FPTase inhibitory activity.
  • Isolation and structure determination of active compounds (kampanols).
  • Biochemical assays to determine the inhibitory potency (IC50) against human recombinant FPTase.

Main Results:

  • Isolation of novel FPTase inhibitors, termed kampanols.
  • Kampanols demonstrated specific inhibition of FPTase.
  • The most potent kampanols exhibited IC50 values ranging from 7 to 13 microM against human recombinant FPTase.

Conclusions:

  • Kampanols are novel and specific inhibitors of farnesyl-protein transferase.
  • These compounds hold promise as potential anticancer agents for tumors with mutated ras oncogenes.
  • Further investigation into kampanols' therapeutic efficacy is warranted.

More Related Videos

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein07:08

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Published on: January 16, 2020

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...